Literature DB >> 8287229

dbl oncogene expression in childhood tumors and tumor cell lines.

S Navarro1, A Pellín, R Noguera, M P Díaz, M Tsokos, T J Triche, A Llombart-Bosch.   

Abstract

We studied the expression of the dbl oncogene in the total RNA obtained from a wide spectrum of childhood tumors, including Ewing's sarcomas, peripheral neuroectodermal tumors (PNET), esthesioneuroblastomas, neuroblastomas, retinoblastomas, rhabdomyosarcomas, osteosarcomas, and synovial sarcomas. Material was obtained from primary tumors, nude mice xenografts, and tumor cell lines. Following the Northern blot technique, a single band of 2.8 kb was found in each analyzed case. Induction of neural differentiation in Ewing's sarcoma, peripheral PNET, and neuroblastoma cell lines with dibutyryl cyclic AMP did not change the expression of the dbl oncogene. We conclude that the wide expression of the dbl oncogene in these childhood tumors reduces its value as a molecular marker for their differential diagnosis; on the other hand, the dbl oncogene does not appear to be an essential molecular factor in the process of neuroectodermal differentiation of small round cell tumors of childhood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287229

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  3 in total

1.  Major histocompatibility complex class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line.

Authors:  P E Harris; A I Colovai; A Maffei; Z Liu; N S Foca
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

2.  Tyrosine phosphorylation of Dbl regulates GTPase signaling.

Authors:  Meghana Gupta; Xiaojun Qi; Varsha Thakur; Danny Manor
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

3.  Advanced adult esthesioneuroblastoma successfully treated with cisplatin and etoposide alternated with doxorubicin, ifosfamide and vincristine.

Authors:  Salvatore Turano; Candida Mastroianni; Caterina Manfredi; Rosalbino Biamonte; Silvia Ceniti; Virginia Liguori; Rosanna De Simone; Serafino Conforti; Aldo Filice; Antonio Rovito; Caterina Viscomi; Giuseppe Patitucci; Salvatore Palazzo
Journal:  J Neurooncol       Date:  2009-11-19       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.